Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Berlex Biosciences Signs Document Management Software Agreement with Qumas, Inc.


SAN FRANCISCO--(BUSINESS WIRE)--June 21, 1999--

Berlex Biosciences, a division of Berlex Laboratories Introduction
Berlex Laboratories, Incorporated is a research-based pharmaceutical company headquartered in Montville, New Jersey with operations in Wayne, New Jersey; Bothell, Washington; Seattle, Washington; and Richmond, California.
, Inc., today signed an agreement with Qumas, Inc. for Qumas Doc, a document management system developed to manage electronic document revision control Revision control (also known as version control (system) (VCS), source control or (source) code management (SCM)) is the management of multiple revisions of the same unit of information.  for regulated industries. The agreement is the latest in a number of deals Qumas has signed with healthcare corporations in Ireland, Holland, New Jersey and California.

The announcement was made at a reception attended by Irish minister for Trade, Tom Kitt Tom Kitt (Irish: Tomás Ó Ceit; born 11 July, 1952), is a senior Irish Fianna Fáil politician and the current Government Chief Whip. He has been a TD for Dublin South since 1987.

Tom Kitt was born in Galway and educated at St.
, T.D., Enterprise Ireland This article or section needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article.  CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Dan Flinter and representatives from Berlex Biosciences, Richmond, CA.

David Cronin, Director Qumas Inc, commenting on the agreement said, "We're delighted to be working with a customer of the caliber of Berlex Biosciences. Qumas has worked closely with Enterprise Ireland to identify and develop business opportunities internationally, and the organization's West Coast office has been particularly successful in this regard."

About Qumas

Qumas Doc was developed to manage electronic document revision control for regulated industries and has proved to be the first choice of some of the worlds leading Pharmaceutical, Medical Device and Biotech companies.

Qumas, based in Ireland, has offices in Brussels, New Jersey and, most recently, San Francisco. The company's dedication to ensuring the highest standard in the area of development and support has earned them the 9001-ISO 9000-3 TICKIT TickIT - A software industry quality assessment scheme.  accreditation.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 21, 1999
Words:215
Previous Article:National Semiconductor Introduces Dual Digital Downconverter Optimized for Base Station Receivers.
Next Article:Intel Offers New PC Camera Product to Meet Consumer Demand for Basic Camera and Communications Features; Intel PC Camera Pack Priced at $79 MSRP.
Topics:



Related Articles
Bradley and Berlex agree to amend original Deconamine purchase agreement.
BRADLEY PHARMACEUTICALS Fulfills its Commitment to File Registration Statement for Previously Issued Shares to Berlex Laboratories.
Broad-Based QUADRAMET Marketing Campaign Announced; Large Specialized Berlex Sales Force Will Reach More Prescribing Physicians in Cancer Pain...
Berlex Licenses DoubleTwist Clustering and Alignment Tools.
DUSA Pharmaceuticals, Inc. -- DUSA Reports Filing Of BLU-U PMA Supplement.
Phase-1 Molecular Toxicology Announces Research Collaboration with Schering AG.
CDC Solutions' EZsubs Software Provides Out-of-the-Box Publishing Solution for International Biopharmaceutical Innovator, Cephalon.
Cellegy Selects QUMAS DocCompliance to Manage Regulatory and Clinical Documentation.
Eugene biomedical supplier signs licensing agreement.
QUMAS.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles